Sanofi and Kling Bio have entered into a partnership aimed at accelerating the discovery of neutralising antibodies. The ...

Despite adequate availability of nirsevimab, only about one third of eligible children receive it for respiratory syncytial virus prophylaxis, with uptake varying by race and other social factors.

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages - including the XFG and NB.1.8.1 variants1 - compared to ...

Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

U.S. health secretary Robert F. Kennedy Jr.'s changes to federal vaccine policy are prompting medical organizations and ...